Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: KX1N4TV7UY

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Coagulation factor XI inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Atrial Fibrillation 3 D001281 ClinicalTrials
Venous Thromboembolism 3 D054556 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4650369
FDA SRS KX1N4TV7UY